Meilang Xue | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications


  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025


  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024


  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024


  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024


  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024


 

Guoxin Ni | Medicine and Dentistry | Best Researcher Award

Prof. Guoxin Ni | Medicine and Dentistry | Best Researcher Award

First Affiliated Hospital of Xiamen University | China

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Prof. Guoxin Ni embarked on his academic journey with a strong foundation in [specific field], earning his [degree] from [university] in [year]. His early years were marked by an insatiable curiosity and dedication to understanding [relevant subject], which laid the groundwork for his future contributions to academia and research.

🌟 Professional Endeavors

Over the years, Prof. Ni has been associated with esteemed institutions such as [institution names], where he has played a pivotal role in [teaching/research]. As a [current position] at [university/institution], he has been instrumental in shaping the academic landscape, mentoring students, and spearheading research initiatives that push the boundaries of [field of expertise].

🔬 Contributions and Research Focus

Prof. Ni’s research is centered on [key research areas], where he has made groundbreaking discoveries in [specific topic]. His work on [notable research or project] has been widely recognized, contributing significantly to the advancement of [industry/academic field]. His innovative approaches and methodologies have paved the way for new understandings and applications in [related domain].

🏆 Accolades and Recognition

A recipient of numerous awards, Prof. Ni’s excellence has been acknowledged through [list of notable awards and honors]. His contributions have been celebrated in [journals/conferences], and he continues to be a sought-after speaker and expert in his field.

🌐 Impact and Influence

Beyond academia, Prof. Ni has influenced the broader [industry/field] community through collaborations with [organizations/industries]. His work has inspired budding researchers and professionals alike, setting new benchmarks for innovation and excellence. His leadership in [specific initiative or research group] has fostered a culture of exploration and intellectual growth.

💪 Legacy and Future Contributions

Looking ahead, Prof. Ni remains committed to advancing research in [field], with ongoing projects aimed at [future research direction]. His vision and dedication continue to drive progress, ensuring a lasting legacy in both academic and professional circles. His impact will undoubtedly shape the future of [industry or field] for generations to come.

 

Publications


📄 Mechanosensitive lncRNA H19 promotes chondrocyte autophagy, but not pyroptosis, by targeting miR-148a in post-traumatic osteoarthritis
Authors: Xuchang Zhou, Hong Cao, Tao Liao, Shengyao Liu, Guoxin Ni
Journal: Non-coding RNA Research
Year: 2025


📄 Antioxidant taurine inhibits chondrocyte ferroptosis through upregulation of OGT/Gpx4 signaling in osteoarthritis induced by anterior cruciate ligament transection
Authors: Xuchang Zhou, Yajing Yang, Xu Qiu, Donghai Lin, Guoxin Ni
Journal: Journal of Advanced Research
Year: 2025


📄 Translation, Cross-Culture Adaptation and Measurement Properties of the Simplified Chinese Version of the Osteoarthritis Knowledge Scale
Authors: Ziru Wang, Ben Darlow, Huili Deng, Guoxin Ni
Journal: Musculoskeletal Care
Year: 2024


📄 Tetrathiomolybdate alleviates osteoporosis by activating the PI3K/AKT signaling axis
Authors: Xuchang Zhou, C.H. Cao, Dongxue Wang, Shengyao Liu, Guoxin Ni
Journal: European Cells and Materials
Year: 2024


📄 Evaluation of Quantitative and Selective Sensory Fiber Dysfunction in Patients with Cirrhosis
Authors: Nannan Zhang, Zhiyong Wang, Jianmin Chen, Guoxin Ni, Jun Ni
Journal: Current Neurovascular Research
Year: 2024


Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Dr. Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Toronto Western Hospital, University of Toronto | Canada

Author Profile

Scopus

📚 Early Academic Pursuits

Dr. Fadi Kharouf's academic journey began with a passion for [his specialization], leading him to pursue rigorous studies in [his major] at [his university]. His early academic years were marked by exceptional dedication, laying the foundation for his future research and professional endeavors.

💼 Professional Endeavors

Dr. Kharouf's career spans across academia and industry, where he has made significant contributions as a [his position] at [his institution/organization]. His expertise in [specific areas of expertise] has led to groundbreaking advancements, positioning him as a key figure in [his field].

🔬 Contributions and Research Focus

With a deep focus on [his primary research areas], Dr. Kharouf has worked extensively on [specific research projects or innovations]. His work on [notable findings or methodologies] has been instrumental in shaping new perspectives in [his domain]. His research has not only expanded theoretical knowledge but also paved the way for practical applications in [relevant industries].

🏅 Accolades and Recognition

Dr. Kharouf's contributions have earned him numerous awards and honors, recognizing his excellence in research and innovation. His work has been published in prestigious journals, and he has been invited as a keynote speaker at major conferences, reflecting his influence and thought leadership.

🌍 Impact and Influence

Beyond academia, Dr. Kharouf's impact extends to mentoring young researchers, collaborating on international projects, and contributing to policy-making in [his field]. His ability to bridge the gap between research and real-world applications has made a lasting impact on [his industry or academic community].

🚀 Legacy and Future Contributions

As Dr. Kharouf continues to push the boundaries of knowledge, his legacy is defined by his commitment to excellence and innovation. His ongoing work promises to further revolutionize [his domain], inspiring future generations to follow in his footsteps.

Publications


  • 📄The association between cigarette smoking and radiographic progression in Psoriatic Arthritis

    • Authors: Fadi Kharouf, Hernán H. Maldonado-Ficco, Shangyi S. Gao, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis

    • Authors: Fadi Kharouf, Pankti P. Mehta, Shangyi S. Gao, Dafna D.D. Gladman, Vinod V. Chandran
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Degenerative Disc Disease In Young Adults With Psoriatic Arthritis

    • Authors: Fadi Kharouf, Shangyi S. Gao, D. Pereira, R.J. Cook, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Journal of Rheumatology
    • Year: 2025

  • 📄Updates on Recent Advances in the Therapy of Adult Psoriatic Disease

    • Authors: Fadi Kharouf, Dafna D.D. Gladman
    • Journal: Current Rheumatology Reviews
    • Year: 2025

  • 📄Lupus nephritis: Biomarkers

    • Authors: C. Dobrowolski, S.M. Lao, Fadi Kharouf, P.P. Croci, J. Wither, D.D. Gladman, L.W. Garcia, A. Jauhal, Z. Touma
    • Journal: Advances in Clinical Chemistry
    • Year: 2025

 

Linmang Qin | Medicine and Dentistry | Best Researcher Award

Prof. Linmang Qin | Medicine and Dentistry | Best Researcher Award

Guangdong Provincial People's Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Prof. Lin Mang Qin pursued a Bachelor's degree in Clinical Medicine from Jiujiang University, where he ranked in the top 1% based on comprehensive assessments. He continued his academic journey by completing a Master's degree in Clinical Medicine at South China University of Technology, earning first-class academic scholarships each year during his master's studies.

Professional Endeavors

Currently serving as a Scientific Research Assistant at Guangdong Provincial People’s Hospital since August 2022, Prof. Qin has been deeply involved in theoretical studies, clinical work, and scientific research over the past four years. His responsibilities include conducting basic scientific research at the hospital's public experimental platform and supervising scientific research experiments.

Contributions and Research Focus

Prof. Qin has contributed significantly to the field of clinical medicine, particularly in areas related to autoimmune diseases and gene expression analysis. His research focuses on topics such as fibroblast mesenchymal transition in systemic sclerosis-associated interstitial lung disease (SSc-ILD) and gene expression profiling in polymyositis.

Accolades and Recognition

Prof. Qin's research has garnered international recognition, with publications in prestigious journals such as "iScience" and "Heliyon." Notably, his work has been nominated for the Best Researcher Award, and his methods have been praised by journals for their potential impact on the scientific community.

Impact and Influence

Prof. Qin's research has contributed to advancing our understanding of autoimmune diseases and gene expression regulation, potentially paving the way for novel therapeutic interventions. His involvement in national natural science projects and collaborations with esteemed institutions reflect his impactful contributions to the scientific community.

Legacy and Future Contributions

As the team leader of the public experimental platform at Guangdong Provincial People's Hospital, Prof. Qin continues to mentor and train aspiring researchers while actively engaging in cutting-edge scientific research. His proficiency in various scientific research techniques and dedication to advancing medical knowledge position him as a leader in the field, with a promising future marked by continued innovation and discovery.

Notable Publications

CD4+LAG3+T cells are decreased in SSc-ILD and affect fibroblast mesenchymal transition by TGF-β3 2023

Screening and validation of differentially expressed genes in polymyositis 2024